ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1153

Perceived Health-Related Quality of Life and Its Determining Factors in Children with Recent-Onset JIA

Jens Klotsche1, Ina Liedmann1, Martina Niewerth2, Gerd Horneff3, Johannes Peter Haas4 and Kirsten Minden5, 1Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz institute, Berlin, Germany, 2Epidemiology, German Rheumatism Research Centre, Berlin, Germany, 3Department of Pediatrics, Centre of Pediatric Rheumatology, Sankt Augustin, Germany, 4German Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany, 5Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease and a major cause of chronic disability in children aged below 16 years. Health-related quality of life (HrQoL) has become an important outcome measure for the perceived burden of disease and therapy effectiveness in the field of pediatric rheumatology. There is little knowledge about its diversification and determining factors in children with recently diagnosed JIA.

Methods: The diversification and determining factors of HrQoL were investigated by latent class analyses (LCA) in the ICON (Inception Cohort Of Newly-diagnosed patients with JIA) study, a prospective controlled observational multicentere study for long-term observation of patients diagnosed as JIA within the last 12 months. The evaluation comprised a self assessment by patients and parents via standardized questionnaires and clinical examinations by pediatric rheumatologists and ophthalmologists. HrQoL was measured by the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales and the PedsQL 3.0 Rheumatology Module. The PedsQL was completed by patients above an age of eight years and parents. The difference between both ratings and determining factors for the difference were investigated.

Results: Information about HrQoL was available for 426 patients. Differences in the patients and parents ratings could be investigated for 198 children aged above 8 years. More than half of the children (58.4%) were assigned to a group characterized by high PedsQL scores (range: 79.4, 95% CI: 76.3;82.5 for treatment problems to 98.3, 95% CI: 97.5;99.2 for daily activity) by LCA. Only 9% of the children were classified into a group with low HrQoL scores (mean total score 50.6, 95% CI: 45.3;55.9) and were diagnosed with polyarthrits. High HrQoL scores were associated with the ILAR category oligoarthritis (p<0.001) and a low disease activity (mean 2.7 on NRS 0-10, p<0.001). Patients with high HrQoL scores had significantly less emotional difficulties as measured by the Strength and Difficulties questionnaire. Interestingly, parents of patients with higher HrQoL scores had more likely a higher educational level (57% with more than 10 years of schooling). In general, the parents rating of HrQoL was lower than the rating of the children (difference in total score = 4.1, 95%CI: 2.5;5.7). The most pronounced differences were observed in the rating of emotional problems (Δ=8.3, 95%CI: 5.3;11.2) within the age groups (Δ=6.0 for age group 8-12 years versus 1.8 for age group 13-16 years, p<0.001). Children in the two ILAR categories systemic arthritis (Δ=8.8, 95%CI: 3.6;14.1) and psoriatic arthritis (Δ=6.6; 95%CI: 1.2;13.5) reported better HrQoL compared to the parents report.

Conclusion: More than half of the children report high HrQoL scores at the beginning of JIA. Disease related parameters as well as social and personal factors independently affect the patients´ overall well-being. Parents of younger children rated HrQoL remarkably lower than the children themselves, both patient- and proxy-reporting is therefore required to get a full picture of the burden of illness.


Disclosure:

J. Klotsche,
None;

I. Liedmann,
None;

M. Niewerth,
None;

G. Horneff,

Abbott Immunology Pharmaceuticals,

2,

Pfizer Inc,

2;

J. P. Haas,
None;

K. Minden,

Pfizer Inc,

2,

Pfizer Inc, Abbott, Novartis, Chugai, Roche, Medac,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perceived-health-related-quality-of-life-and-its-determining-factors-in-children-with-recent-onset-jia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology